Peijia Medical Limited
PEJMF
$1.39
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 45.87% | 47.03% | 29.61% | 27.65% | 61.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.87% | 47.03% | 29.61% | 27.65% | 61.19% |
| Cost of Revenue | 56.47% | 57.72% | 53.47% | 51.15% | 60.96% |
| Gross Profit | 41.43% | 42.56% | 22.45% | 20.59% | 61.29% |
| SG&A Expenses | 14.69% | 15.60% | -11.61% | -12.95% | 7.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.07% | 46.65% | -515.91% | -506.68% | -70.12% |
| Total Operating Expenses | 14.98% | 15.90% | 1.79% | 0.25% | 24.07% |
| Operating Income | 21.39% | 20.76% | 41.85% | 42.73% | 2.40% |
| Income Before Tax | 14.63% | 13.95% | 68.67% | 69.14% | 42.18% |
| Income Tax Expenses | 810.58% | 818.01% | 350.23% | 343.86% | -95.27% |
| Earnings from Continuing Operations | 12.57% | 11.87% | 67.48% | 67.97% | 43.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13,150.00% | 13,210.00% | -30.00% | -30.00% | -- |
| Net Income | 13.62% | 12.93% | 67.48% | 67.97% | 43.76% |
| EBIT | 21.39% | 20.76% | 41.85% | 42.73% | 2.40% |
| EBITDA | 31.60% | 31.06% | 50.41% | 51.16% | 4.73% |
| EPS Basic | 10.38% | 10.38% | 67.71% | 68.12% | 44.55% |
| Normalized Basic EPS | 23.48% | 23.48% | 45.78% | 47.06% | -88.52% |
| EPS Diluted | 10.38% | 10.38% | 67.71% | 68.12% | 44.55% |
| Normalized Diluted EPS | 23.48% | 23.48% | 45.78% | 47.06% | -88.52% |
| Average Basic Shares Outstanding | -3.16% | -3.16% | 0.29% | 0.29% | 1.04% |
| Average Diluted Shares Outstanding | -3.16% | -3.16% | 0.29% | 0.29% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |